Tenzing Acquisition (TZAC) Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.

No competitors for Tenzing Acquisition were found.

Get Tenzing Acquisition News Delivered to You Automatically

TZAC vs. The Competition

Metric	Tenzing Acquisition	Pharmaceutical Preparations Industry	Sector	NASDAQ Exchange
Market Cap	$15.32M	$6.49B	$1.84B	$7.63B
Dividend Yield	N/A	3.07%	15.24%	3.94%
P/E Ratio	N/A	10.30	10.25	18.08
Price / Sales	N/A	302.97	9,838.06	82.65
Price / Cash	143.10	29.68	105.61	35.09
Price / Book	3.05	5.93	0.75	4.38
Net Income	$620,000.00	$141.55M	-$50.22M	$214.23M

Top 10 Stock Comparisons

This page (NASDAQ:TZAC) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.